IL22 and Alzheimer disease: Its mechanism of action targets key pro-inflammatory cytokines involved in both Th1- and Th2-mediated pathways, such as IFN-γ, IL-4, IL-13, and IL-22, offering a rationale for its efficacy in complex immune-mediated conditions like AD and AA [29].